1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 5
FEATURED COMPANIES
- B. Braun Melsungen
- BD
- Boston Scientific
- Cardinal Health
- Medtronic
- MORE
About plaque modification devices
Plaque modification devices clear out the blockage in the arteries, helping them regain their normal function resulting in improved blood circulation and heart function. Plaque in the arteries is a deposition of fat on the walls of arteries, that narrow the artery and reduce blood flow.
The analysts forecast the Global Plaque Modification Devices Market to grow at a CAGR of 8.19% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the plaque modification devices market. To calculate the market size, the report considers the revenue generated from the sales of different plaque modification devices offered to end-users such as hospitals, ambulatory care centers (ACC), and others.
The market is divided into the following segments based on geography:
Key vendors
Plaque modification devices clear out the blockage in the arteries, helping them regain their normal function resulting in improved blood circulation and heart function. Plaque in the arteries is a deposition of fat on the walls of arteries, that narrow the artery and reduce blood flow.
The analysts forecast the Global Plaque Modification Devices Market to grow at a CAGR of 8.19% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the plaque modification devices market. To calculate the market size, the report considers the revenue generated from the sales of different plaque modification devices offered to end-users such as hospitals, ambulatory care centers (ACC), and others.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Key vendors
- B. Braun Melsungen
- BD
- Boston Scientific
- Cardinal Health
- Medtronic
- Rising incidence of CADs
- For a full, detailed list, view the full report
- Lack of accessibility and affordability in developing countries
- For a full, detailed list, view the full report
- Increasing M&A
- For a full, detailed list, view the full report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Note: Product cover images may vary from those shown
2 of 5
FEATURED COMPANIES
- B. Braun Melsungen
- BD
- Boston Scientific
- Cardinal Health
- Medtronic
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
PART 12: DRIVERS AND CHALLENGES
Exhibit 01: Parent market
Exhibit 02: Global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Product - Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Thrombectomy devices - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Thrombectomy devices - Year-over-year growth 2018-2022 (%)
Exhibit 22: Atherectomy devices - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Atherectomy devices - Year-over-year growth 2018-2022 (%)
Exhibit 24: CTO devices - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: CTO devices - Year-over-year growth 2018-2022 (%)
Exhibit 26: EPD - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: EPD - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global - Market share by geography 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 34: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: B. Braun Melsungen: Overview
Exhibit 46: B. Braun Melsungen: Business segments
Exhibit 47: B. Braun Melsungen: Organizational developments
Exhibit 48: B. Braun Melsungen: Geographic focus
Exhibit 49: B. Braun Melsungen: Segment focus
Exhibit 50: B. Braun Melsungen: Key offerings
Exhibit 51: BD: Overview
Exhibit 52: BD - Business segments
Exhibit 53: BD - Organizational developments
Exhibit 54: BD - Geographic focus
Exhibit 55: BD - Segment focus
Exhibit 56: BD - Key offerings
Exhibit 57: Boston Scientific: Overview
Exhibit 58: Boston Scientific - Business segments
Exhibit 59: Boston Scientific - Organizational developments
Exhibit 60: Boston Scientific - Geographic focus
Exhibit 61: Boston Scientific - Segment focus
Exhibit 62: Boston Scientific - Key offerings
Exhibit 63: Cardinal Health: Overview
Exhibit 64: Cardinal Health - Business segments
Exhibit 65: Cardinal Health - Organizational developments
Exhibit 66: Cardinal Health - Geographic focus
Exhibit 67: Cardinal Health - Segment focus
Exhibit 68: Cardinal Health - Key offerings
Exhibit 69: Medtronic: Overview
Exhibit 70: Medtronic - Business segments
Exhibit 71: Medtronic - Organizational developments
Exhibit 72: Medtronic - Geographic focus
Exhibit 73: Medtronic - Segment focus
Exhibit 74: Medtronic - Key offerings
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Segmentation by product
- Comparison by product
- Thrombectomy devices - Market size and forecast 2016-2021
- Atherectomy devices - Market size and forecast 2016-2021
- CTO devices - Market size and forecast 2016-2021
- EPD - Market size and forecast 2016-2021
- Market opportunity by product
PART 09: MARKET SEGMENTATION BY END-USER
- Segmentation by end-user
- Hospitals
- ACC
- Others
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Increasing M&A
- Technological advances
- Commoditization of plaque modification devices
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- B. Braun Melsungen
- BD
- Boston Scientific
- Cardinal Health
- Medtronic
- List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Product - Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Thrombectomy devices - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Thrombectomy devices - Year-over-year growth 2018-2022 (%)
Exhibit 22: Atherectomy devices - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Atherectomy devices - Year-over-year growth 2018-2022 (%)
Exhibit 24: CTO devices - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: CTO devices - Year-over-year growth 2018-2022 (%)
Exhibit 26: EPD - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: EPD - Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Global - Market share by geography 2017-2022 (%)
Exhibit 31: Regional comparison
Exhibit 32: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 34: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: B. Braun Melsungen: Overview
Exhibit 46: B. Braun Melsungen: Business segments
Exhibit 47: B. Braun Melsungen: Organizational developments
Exhibit 48: B. Braun Melsungen: Geographic focus
Exhibit 49: B. Braun Melsungen: Segment focus
Exhibit 50: B. Braun Melsungen: Key offerings
Exhibit 51: BD: Overview
Exhibit 52: BD - Business segments
Exhibit 53: BD - Organizational developments
Exhibit 54: BD - Geographic focus
Exhibit 55: BD - Segment focus
Exhibit 56: BD - Key offerings
Exhibit 57: Boston Scientific: Overview
Exhibit 58: Boston Scientific - Business segments
Exhibit 59: Boston Scientific - Organizational developments
Exhibit 60: Boston Scientific - Geographic focus
Exhibit 61: Boston Scientific - Segment focus
Exhibit 62: Boston Scientific - Key offerings
Exhibit 63: Cardinal Health: Overview
Exhibit 64: Cardinal Health - Business segments
Exhibit 65: Cardinal Health - Organizational developments
Exhibit 66: Cardinal Health - Geographic focus
Exhibit 67: Cardinal Health - Segment focus
Exhibit 68: Cardinal Health - Key offerings
Exhibit 69: Medtronic: Overview
Exhibit 70: Medtronic - Business segments
Exhibit 71: Medtronic - Organizational developments
Exhibit 72: Medtronic - Geographic focus
Exhibit 73: Medtronic - Segment focus
Exhibit 74: Medtronic - Key offerings
Note: Product cover images may vary from those shown
3 of 5
FEATURED COMPANIES
- B. Braun Melsungen
- BD
- Boston Scientific
- Cardinal Health
- Medtronic
- MORE
New Report Released: - Global Plaque Modification Devices Market 2018-2022.
The author of the report recognizes the following companies as the key players in the plaque modification devices market: B. Braun Melsungen, BD, Boston Scientific, Cardinal Health, Medtronic.
Commenting on the report, an analyst from the research team said: “The increasing M&A will be a key trend driving the market growth. The marketplace is witnessing several acquisitions that expand the businesses of companies by improving their technical know-how and expand their product offerings. Increasing M&As aid companies in improving their product portfolio and boost the availability of such products.”
According to the report, the rising incidence of CADs will drive the market growth. CVDs are among the top five causes of death globally and has the highest prevalence among heart diseases such as CAD, rheumatic heart diseases, and strokes. Recent advances in cardiovascular care results in the emergence of minimal-invasive interventional techniques using plaque modification devices.
Further, the report states that the lack of accessibility and affordability in developing countries will impact the market growth. In developing countries with high disease burden, treatments for cardiovascular ailments are neither affordable nor accessible. These regions are challenged by factors such as poor healthcare facilities, lack of diagnostic and pathology services, and lack of a trained oncology workforce.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The author of the report recognizes the following companies as the key players in the plaque modification devices market: B. Braun Melsungen, BD, Boston Scientific, Cardinal Health, Medtronic.
Commenting on the report, an analyst from the research team said: “The increasing M&A will be a key trend driving the market growth. The marketplace is witnessing several acquisitions that expand the businesses of companies by improving their technical know-how and expand their product offerings. Increasing M&As aid companies in improving their product portfolio and boost the availability of such products.”
According to the report, the rising incidence of CADs will drive the market growth. CVDs are among the top five causes of death globally and has the highest prevalence among heart diseases such as CAD, rheumatic heart diseases, and strokes. Recent advances in cardiovascular care results in the emergence of minimal-invasive interventional techniques using plaque modification devices.
Further, the report states that the lack of accessibility and affordability in developing countries will impact the market growth. In developing countries with high disease burden, treatments for cardiovascular ailments are neither affordable nor accessible. These regions are challenged by factors such as poor healthcare facilities, lack of diagnostic and pathology services, and lack of a trained oncology workforce.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
- B. Braun Melsungen
- BD
- Boston Scientific
- Cardinal Health
- Medtronic
Note: Product cover images may vary from those shown
5 of 5
LOADING...
